Search research articles
Contact Us
Filters
Showing results (191-200 of 787) with videos related to
Page
of 79
Sort By:
Revue Medicale De Liege
|
April 29, 1998
[Syndrome X, at the crossroads of metabolic and cardiovascular diseases]
A J Scheen
Diabetes & Metabolism
|
June 30, 2001
Thiazolidinediones and liver toxicity
A J Scheen
Revue Medicale De Liege
|
September 1, 1994
[Drug of the month. Sertraline (Serlain)]
A J Scheen
Revue Medicale De Liege
|
May 1, 1994
[Drug of the month. Moclobemide (Aurorix)]
A J Scheen
Revue Medicale De Liege
|
January 1, 1995
[Nitric oxide (NO.), a new therapeutic purpose]
A J Scheen
Revue Medicale De Liege
|
June 23, 2006
[Clinical study of the month: ASTEROID: regression of coronary atherosclerosis with rosuvastatin at a maximal daily dose of 40 mg]
A J Scheen
Revue Medicale De Liege
|
August 30, 2007
[Epilogue of the "therapeutic memory"...]
A J Scheen
Revue Medicale De Liege
|
July 23, 2005
[Towards a tripple oral therapy in the pharmacological treatment of type 2 diabetes?]
A J Scheen
Revue Medicale De Liege
|
November 23, 2006
[The CHARISMA study: in search of the best antiplatelet strategy for cardiovascular prevention]
A J Scheen
Revue Medicale De Liege
|
May 27, 2010
[NAVIGATOR: A trial of prevention of cardiovascular complications and type 2 diabetes with valsartan and/or nateglinide]
A J Scheen
Page
of 79
Search research articles
Search
Showing results (191-200 of 787) with videos related to
Sort By:
Page
of 79
Revue Medicale De Liege
|
April 29, 1998
[Syndrome X, at the crossroads of metabolic and cardiovascular diseases]
A J Scheen
Diabetes & Metabolism
|
June 30, 2001
Thiazolidinediones and liver toxicity
A J Scheen
Revue Medicale De Liege
|
September 1, 1994
[Drug of the month. Sertraline (Serlain)]
A J Scheen
Revue Medicale De Liege
|
May 1, 1994
[Drug of the month. Moclobemide (Aurorix)]
A J Scheen
Revue Medicale De Liege
|
January 1, 1995
[Nitric oxide (NO.), a new therapeutic purpose]
A J Scheen
Revue Medicale De Liege
|
June 23, 2006
[Clinical study of the month: ASTEROID: regression of coronary atherosclerosis with rosuvastatin at a maximal daily dose of 40 mg]
A J Scheen
Revue Medicale De Liege
|
August 30, 2007
[Epilogue of the "therapeutic memory"...]
A J Scheen
Revue Medicale De Liege
|
July 23, 2005
[Towards a tripple oral therapy in the pharmacological treatment of type 2 diabetes?]
A J Scheen
Revue Medicale De Liege
|
November 23, 2006
[The CHARISMA study: in search of the best antiplatelet strategy for cardiovascular prevention]
A J Scheen
Revue Medicale De Liege
|
May 27, 2010
[NAVIGATOR: A trial of prevention of cardiovascular complications and type 2 diabetes with valsartan and/or nateglinide]
A J Scheen
Page
of 79